Philip D. Poorvu

1.5k total citations
44 papers, 718 citations indexed

About

Philip D. Poorvu is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Philip D. Poorvu has authored 44 papers receiving a total of 718 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 13 papers in Cancer Research and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Philip D. Poorvu's work include Breast Cancer Treatment Studies (12 papers), Advanced Breast Cancer Therapies (9 papers) and Cancer Risks and Factors (8 papers). Philip D. Poorvu is often cited by papers focused on Breast Cancer Treatment Studies (12 papers), Advanced Breast Cancer Therapies (9 papers) and Cancer Risks and Factors (8 papers). Philip D. Poorvu collaborates with scholars based in United States, Canada and Italy. Philip D. Poorvu's co-authors include Ann H. Partridge, Shoshana M. Rosenberg, Kathryn J. Ruddy, Virginia F. Borges, Steven E. Come, Jeffrey Peppercorn, Rulla M. Tamimi, Lidia Schapira, Shari Gelber and Elizabeth S. Ginsburg and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Philip D. Poorvu

40 papers receiving 706 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philip D. Poorvu United States	15	345	196	179	145	133	44	718
M. Caroline Vos Netherlands	20	529 1.5×	206 1.1×	108 0.6×	271 1.9×	110 0.8×	57	1.1k
Meghan E. Meyer United States	10	464 1.3×	319 1.6×	306 1.7×	193 1.3×	64 0.5×	17	884
Marianne Phillips Australia	14	461 1.3×	236 1.2×	265 1.5×	61 0.4×	157 1.2×	32	981
Marianne A. Kuenen Netherlands	11	465 1.3×	174 0.9×	133 0.7×	46 0.3×	267 2.0×	15	1.2k
Laurence Vanlemmens France	15	675 2.0×	119 0.6×	244 1.4×	62 0.4×	198 1.5×	70	961
Margriet van der Heiden‐van der Loo Netherlands	20	383 1.1×	229 1.2×	472 2.6×	78 0.5×	163 1.2×	67	1.1k
V. Duric Australia	11	398 1.2×	79 0.4×	163 0.9×	56 0.4×	112 0.8×	17	716
Alison H. Brand Australia	21	549 1.6×	127 0.6×	93 0.5×	461 3.2×	116 0.9×	73	1.4k
Shari Damast United States	15	308 0.9×	89 0.5×	95 0.5×	207 1.4×	83 0.6×	43	896
Weijiang Liang China	12	357 1.0×	41 0.2×	145 0.8×	85 0.6×	105 0.8×	23	639

Countries citing papers authored by Philip D. Poorvu

Since Specialization

Citations

This map shows the geographic impact of Philip D. Poorvu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip D. Poorvu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip D. Poorvu more than expected).

Fields of papers citing papers by Philip D. Poorvu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip D. Poorvu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip D. Poorvu. The network helps show where Philip D. Poorvu may publish in the future.

Co-authorship network of co-authors of Philip D. Poorvu

This figure shows the co-authorship network connecting the top 25 collaborators of Philip D. Poorvu. A scholar is included among the top collaborators of Philip D. Poorvu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip D. Poorvu. Philip D. Poorvu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Giobbie‐Hurder, Anita, Dorothy D. Sears, Erica L. Mayer, et al.. (2025). Combined intermittent fasting and exercise intervention in patients with metastatic, hormone receptor-positive breast cancer (FastER): a pilot study. Breast Cancer Research and Treatment. 214(2). 171–180.

Zheng, Yue, Shoshana M. Rosenberg, Philip D. Poorvu, et al.. (2024). Estrogen levels in young women with hormone receptor-positive breast cancer on ovarian function suppression therapy. npj Breast Cancer. 10(1). 67–67. 6 indexed citations

Rosenberg, Shoshana M., Yue Zheng, Tal Sella, et al.. (2024). Psychosocial and supportive care concerns of young women living with advanced breast cancer: baseline findings from a prospective virtual support intervention study. Supportive Care in Cancer. 32(6). 336–336.

Sedrak, Mina S., Minji K. Lee, Jingran Ji, et al.. (2024). Palbociclib in adults aged 70 years and older with advanced breast cancer: A phase 2 multicenter trial (Alliance A171601). Journal of Geriatric Oncology. 15(6). 101813–101813. 4 indexed citations

Zheng, Yue, Kathryn J. Ruddy, Philip D. Poorvu, et al.. (2024). Helping ourselves, helping others: the Young Women’s Breast Cancer Study (YWS) – a multisite prospective cohort study to advance the understanding of breast cancer diagnosed in women aged 40 years and younger. BMJ Open. 14(6). e081157–e081157. 5 indexed citations

Lynce, Filipa, Noah Graham, Bose Kochupurakkal, et al.. (2023). Abstract CT188: A phase Ib study of sapacitabine (sapa) and olaparib (ola) in patients (pts) with BRCA1/2-mutated (BRCA1/2m) metastatic breast cancer (MBC). Cancer Research. 83(8_Supplement). CT188–CT188. 3 indexed citations

Morganti, Stefania, Brittany Bychkovsky, Philip D. Poorvu, et al.. (2023). Adjuvant Olaparib for Germline BRCA Carriers With HER2-Negative Early Breast Cancer: Evidence and Controversies. The Oncologist. 28(7). 565–574. 5 indexed citations

Sella, Tal, Yue Zheng, Shoshana M. Rosenberg, et al.. (2022). Body weight changes and associated predictors in a prospective cohort of young breast cancer survivors. Cancer. 128(17). 3158–3169. 10 indexed citations

Freedman, Rachel A., Anna Revette, Adriana Perilla-Glen, et al.. (2022). Acceptability of a companion patient guide to support expert consensus guidelines on surveillance mammography in older breast cancer survivors. Breast Cancer Research and Treatment. 195(2). 141–152. 4 indexed citations

10.

Rosenberg, Shoshana M., Yue Zheng, Shari Gelber, et al.. (2022). Adjuvant endocrine therapy non-initiation and non-persistence in young women with early-stage breast cancer. Breast Cancer Research and Treatment. 197(3). 547–558. 6 indexed citations

11.

Krasne, Margaret, Kathryn J. Ruddy, Philip D. Poorvu, et al.. (2022). Coping strategies and anxiety in young breast cancer survivors. Supportive Care in Cancer. 30(11). 9109–9116. 14 indexed citations

12.

Laws, Alison, Ana C. Garrido-Castro, Philip D. Poorvu, et al.. (2021). Utility of the 21-Gene Recurrence Score in Node-Positive Breast Cancer. PubMed. 35(3502). 77–83. 6 indexed citations

13.

Poorvu, Philip D., Jiani Hu, Yue Zheng, et al.. (2021). Treatment-related amenorrhea in a modern, prospective cohort study of young women with breast cancer. npj Breast Cancer. 7(1). 99–99. 19 indexed citations

14.

Sella, Tal, Philip D. Poorvu, Kathryn J. Ruddy, et al.. (2021). Impact of fertility concerns on endocrine therapy decisions in young breast cancer survivors. Cancer. 127(16). 2888–2894. 32 indexed citations

15.

Schapira, Lidia, Yue Zheng, Shari Gelber, et al.. (2021). Trajectories of fear of cancer recurrence in young breast cancer survivors. Cancer. 128(2). 335–343. 69 indexed citations

16.

Rosenberg, Shoshana M., Judy E. Garber, Hilde Vardeh, et al.. (2021). Clinicopathological features and BRCA1 and BRCA2 mutation status in a prospective cohort of young women with breast cancer. British Journal of Cancer. 126(2). 302–309. 27 indexed citations

17.

Poorvu, Philip D., Shari Gelber, Yue Zheng, et al.. (2020). Pregnancy after breast cancer: Results from a prospective cohort of young women with breast cancer. Cancer. 127(7). 1021–1028. 23 indexed citations

18.

Poorvu, Philip D., Shari Gelber, Shoshana M. Rosenberg, et al.. (2019). Prognostic Impact of the 21-Gene Recurrence Score Assay Among Young Women With Node-Negative and Node-Positive ER-Positive/HER2-Negative Breast Cancer. Journal of Clinical Oncology. 38(7). 725–733. 48 indexed citations

19.

Poorvu, Philip D., Antonio L. Damato, Larissa J. Lee, et al.. (2013). Radiation dose escalation using intensity modulated radiation therapy for gross unresected node-positive endometrial cancer. Practical Radiation Oncology. 4(2). 90–98. 17 indexed citations

20.

Poorvu, Philip D., et al.. (2012). Duodenal and Other Gastrointestinal Toxicity in Cervical and Endometrial Cancer Treated With Extended-Field Intensity Modulated Radiation Therapy to Paraaortic Lymph Nodes. International Journal of Radiation Oncology*Biology*Physics. 85(5). 1262–1268. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact